Organization

  • ALL
  • Research institute
  • New Drug Development Headquarters
  • Rare Disease Headquarters
  • Management Planning Headquarters
  • Founders
  • Founder & CEO

    Mr.Hongsung MOON
      • Chairman, RF Window Co., Ltd.
      • Chairman, ChemOn Inc.
      • President, KD Investment
      • BA in accounting, Dong-Ah Univ.
  • Vice President / CRO

    Ph.D.Keetae KIM
      • Principal Investigator, DGIST, Korea
      • Instructor, Virginia Commonwealth Univ.
      • Senior Scientist, Rexahn Pharm. Rockville, MD, US
      • Senior Scientist, LG Biomedical Institute, San Diego, CA, US
      • Research Fellow, Harvard Medical School
      • PhD, Univ. of Texas at Austin
      • MS and BS, Seoul National Univ.
  • Managing Director & CFO

    Mr.Christopher Lim
      • Strategy Division, BINEX Co., Ltd.
      • Finance & Strategy, Daewoong Pharmaceutical Co., Ltd.
      • M&A Team Head, Eland Group
      • BA in management & economics, Yonsei University
  • Chief Technology Officer / Managing Director

    Ph.D.Jong-Wan Kim
      • OliPass Corporation/ R&D Manager
      • Professor of Research at Dankook University's ITREN.
      • Professor of Nanobiology at Dankook University
      • Doctor of Life Sciences, Dankook University
  • Managing Director & CDO

    Mr.James Lee
      • CrystalGenomics, Inc. Managing Director / New Drug Development
      • HLB Therapeutics, Director / Global RA & Quality Operations
      • CHA Bio, General Manager / Global RA & Quality Operations
      • Baush & Lomb / Sr. QA Manager
      • MSD (Merck & Company) / QC Manager
      • Green Cross / Sr. Lab Analyst
      • MS in Organic Chemistry & BS in Chemistry, Kyung Hee University
  • Chief Technology Officer / Managing Director

    Ph.D.Jong-Wan Kim
      • OliPass Corporation/ R&D Manager
      • Professor of Research at Dankook University's ITREN.
      • Professor of Nanobiology at Dankook University
      • Doctor of Life Sciences, Dankook University
  • Managing Director & CDO

    Mr.James Lee
      • CrystalGenomics, Inc. Managing Director / New Drug Development
      • HLB Therapeutics, Director / Global RA & Quality Operations
      • CHA Bio, General Manager / Global RA & Quality Operations
      • Baush & Lomb / Sr. QA Manager
      • MSD (Merck & Company) / QC Manager
      • Green Cross / Sr. Lab Analyst
      • MS in Organic Chemistry & BS in Chemistry, Kyung Hee University
  • Vice President / CRO

    Ph.D.Keetae KIM
      • Principal Investigator, DGIST, Korea
      • Instructor, Virginia Commonwealth Univ.
      • Senior Scientist, Rexahn Pharm. Rockville, MD, US
      • Senior Scientist, LG Biomedical Institute, San Diego, CA, US
      • Research Fellow, Harvard Medical School
      • PhD, Univ. of Texas at Austin
      • MS and BS, Seoul National Univ.
  • Managing Director & CFO

    Mr.Christopher Lim
      • Strategy Division, BINEX Co., Ltd.
      • Finance & Strategy, Daewoong Pharmaceutical Co., Ltd.
      • M&A Team Head, Eland Group
      • BA in management & economics, Yonsei University
  • Founder & CEO

    Mr.Hongsung MOON
      • Chairman, RF Window Co., Ltd.
      • Chairman, ChemOn Inc.
      • President, KD Investment
      • BA in accounting, Dong-Ah Univ.